Classification of CVS diseases and Pharmacology

Classification of CVS diseases:  

  • hypertension
  • heart failure 
  • arrhythmias
  • angina pectoris
  • atherosclerosis and hyperlipidemia 
  • thrombotic disease
  • peripheral vascular disease 
  • stroke  


1. Hypertension

  • Diuretics: Thiazides, Loop diuretics, Potassium-sparing diuretics.
  • Beta-Blockers: Non-selective, Beta-1 selective.
  • ACE Inhibitors: Enalapril, Lisinopril.
  • Angiotensin II Receptor Blockers (ARBs): Losartan, Valsartan.
  • Calcium Channel Blockers: Dihydropyridines (e.g., Amlodipine), Non-dihydropyridines (e.g., Verapamil, Diltiazem).
  • Renin Inhibitors: Aliskiren.
  • Alpha Blockers: Prazosin.
  • Central Agonists: Clonidine.
  • Vasodilators: Hydralazine.

2. Heart Failure

  • ACE Inhibitors
  • Angiotensin II Receptor Blockers (ARBs)
  • Beta-Blockers
  • Diuretics
  • Aldosterone Antagonists: Spironolactone, Eplerenone.
  • Digitalis Glycosides: Digoxin.
  • Vasodilators
  • SGLT2 Inhibitors: Empagliflozin, Dapagliflozin (recently recognized for their benefits in heart failure).

3. Arrhythmias

  • Sodium Channel Blockers (Class I): Quinidine, Lidocaine.
  • Beta-Blockers (Class II)
  • Potassium Channel Blockers (Class III): Amiodarone, Sotalol.
  • Calcium Channel Blockers (Class IV): Verapamil, Diltiazem.
  • Other Antiarrhythmics: Adenosine, Digoxin.

4. Angina Pectoris

  • Nitrates: Nitroglycerin, Isosorbide mononitrate.
  • Beta-Blockers
  • Calcium Channel Blockers
  • Antiplatelet Agents: Aspirin, Clopidogrel.
  • Potassium Channel Openers: Nicorandil.
  • Ranolazine

5. Atherosclerosis and Hyperlipidemia

  • Statins: Atorvastatin, Simvastatin.
  • Bile Acid Sequestrants: Cholestyramine.
  • Fibrates: Fenofibrate.
  • Niacin
  • PCSK9 Inhibitors: Evolocumab.
  • Ezetimibe

6. Thrombotic Disorders

  • Antiplatelet Agents: Aspirin, Clopidogrel, Ticagrelor.
  • Anticoagulants: Warfarin, Heparin, Direct Oral Anticoagulants (DOACs) like Dabigatran (a direct thrombin inhibitor) and Rivaroxaban (a Factor Xa inhibitor).

7. Peripheral Vascular Diseases

  • Antiplatelet Agents
  • Vasodilators
  • Antihypertensives (as part of comprehensive management)

8. Stroke

  • Anticoagulants
  • Antiplatelet Agents
  • Thrombolytics: Alteplase.

Comments